Literature DB >> 1893769

Ocular disease leads to decreased concentrations of epidermal growth factor in the tear fluid.

G B van Setten1, T Tervo, L Viinikka, K Pesonen, J Perheentupa, A Tarkkanen.   

Abstract

The concentration of epidermal growth factor (EGF) in tear fluid (TF) was recently shown to decrease with increasing tear fluid flow (TFF). The purpose of the present study was to clarify the effects of ocular surface disease on the TF EGF concentrations. Tear fluid samples (n = 243) were collected from diseased eyes by means of blunted glass capillaries. The time of collection was measured for each sample, and the tear fluid flow in the capillaries (TFFc) was calculated. The concentration of human EGF (hEGF) was determined using a time-resolved immunofluorometric assay (TR-IFMA). For statistical analysis diagnosis-dependent multigrouping was performed and the data of the patient groups were compared to the data for a control group. The control material consisted of 271 TF samples collected from healthy eyes before (n = 59) and after stimulation of reflex tearing (n = 212). It was shown that TF specimens of patients (n = 243) contained significantly (p less than 0.001) less EGF (mean 952 pg/ml) than the TF of healthy control individuals before (n = 59 samples; mean 6589 pg/ml) or after stimulation of reflex tearing (n = 212 samples; mean 2762 pg/ml). The EGF concentration of every patient group was significantly lower than that found in the TF of control individuals both before and during reflex tearing (p less than 0.001). The rate of EGF released with TF during collection did not differ significantly between the various groups of patients or from that released with the TF of normal individuals before induction of reflex tearing.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893769     DOI: 10.3109/02713689109001760

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  4 in total

1.  Influence of topical human epidermal growth factor on postkeratoplasty re-epithelialisation.

Authors:  M M Dellaert; T A Casey; S Wiffen; J Gordon; P Johnson; A J Geerards; W J Rijneveld; L Remeijer; P G Mulder; W H Beekhuis
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  Basic fibroblast growth factor in human tear fluid: detection of another growth factor.

Authors:  G B van Setten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

3.  Transforming growth factor-alpha is a constant component of human tear fluid.

Authors:  G van Setten; G Schultz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

4.  Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops.

Authors:  Ria Beck; Oliver Stachs; Anita Koschmieder; Wolfgang G K Mueller-Lierheim; Sabine Peschel; Gysbert-Botho van Setten
Journal:  Case Rep Ophthalmol       Date:  2019-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.